Q3 2024 Gland Pharma Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to Q3 FY24 earnings conference call of Gland Pharma Limited. (Operator Instructions) Please note that this conference is being recorded. And I now hand the conference over to Mr. Ankit Gupta. Thank you and over to you, sir.
Thank you, Sagar. Good evening, everyone. We welcome you to Gland Pharma earnings conference call for Q3 FY24. My name is Ankit and I drive the investments, M&A, and corporate strategy for Gland. I have Mr. Srinivas Sadu, MD and CEO, and Mr. Ravi Mitra, CFO, to discuss business performance and financial highlights for the quarter. We will begin this call with the business highlights by Mr. Sadu, followed by a financial overview by Mr. Ravi.
Before we proceed, please note the Safe Harbor statement that we have on the press release. Some of the statements that we make today will be forward-looking and will be based on the current estimates that management has. These statements must be viewed in
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
